Sheel Biotech (NSE:SHEEL) Marketable Securities: ₹0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SHEEL Sheel Biotech Ltd NSE:SHEEL
19 GF Score
Price ₹58.75
! 2 Warning Signs
View Full Analysis

What is Sheel Biotech Marketable Securities?

Sheel Biotech NSE:SHEEL 19 Marketable Securities is ₹0 Mil as of Mar. 2026. GuruFocus rates NSE:SHEEL with a GF Score™ of 19/100. The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Sheel Biotech's Marketable Securities for the quarter that ended in Mar. 2026 was ₹0 Mil.

Sheel Biotech  (NSE:SHEEL) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Sheel Biotech Marketable Securities Related Terms

Sheel Biotech Marketable Securities Historical Data

* Premium members only.

The historical data trend for Sheel Biotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sheel Biotech Marketable Securities Chart

Sheel Biotech Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
0.00 0.00 0.00 0.00 0.00

Sheel Biotech Semi-Annual Data
Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities 0.00 0.00 0.00 0.00 0.00
NSE:SHEEL
19GF Score
Sheel Biotech Ltd NSE:SHEEL
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sheel Biotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Sheel Biotech (NSE:SHEEL) has a Marketable Securities of ₹0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sheel Biotech and its competitors.
Is Sheel Biotech's Marketable Securities too high?
Sheel Biotech's current Marketable Securities is ₹0 Mil. Overall, Sheel Biotech has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Sheel Biotech's Marketable Securities compare to ADM and BG?
Sheel Biotech's Marketable Securities of ₹0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Consumer Packaged Goods company?
A good Marketable Securities depends on the Consumer Packaged Goods industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sheel Biotech and its competitors. Sheel Biotech's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sheel Biotech stock overvalued right now?
Sheel Biotech (NSE:SHEEL) has a current Marketable Securities of ₹0 Mil. The current Marketable Securities is ₹0 Mil. Sheel Biotech's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Sheel Biotech (NSE:SHEEL), the current Marketable Securities is ₹0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sheel Biotech Business Description

Address Guru Ravidas Marg, 8 Balaji Estates, 2nd Floor, Block-C, Kalkaji, South Delhi, New Delhi, IND, 110019
Sheel Biotech Ltd is engaged in the business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants through tissue culture and organic farming. It manufactures and maintain greenhouses, offer services to farmers and provide training through Farmer Producer Organizations (FPOs). The company also has a Research and Development lab with a capacity of production of 10 million* planting materials which is duly recognized by the Department of Biotechnology (DBT), Government of India.
19GF Score

Get the complete analysis for NSE:SHEEL

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹58.75
Price